Form 8-K - Current report:
SEC Accession No. 0001683168-25-004258
Filing Date
2025-06-05
Accepted
2025-06-05 14:57:32
Documents
27
Period of Report
2025-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT actuate_8k.htm   iXBRL 8-K 38279
2 TRANSCRIPT OF KEY OPINION LEADER EVENT actuate_ex9901.htm EX-99.1 187651
6 GRAPHIC image_001.jpg GRAPHIC 25810
7 GRAPHIC image_002.jpg GRAPHIC 10597
8 GRAPHIC image_017.jpg GRAPHIC 308300
9 GRAPHIC image_018.jpg GRAPHIC 221933
10 GRAPHIC image_019.jpg GRAPHIC 268279
11 GRAPHIC image_020.jpg GRAPHIC 221568
12 GRAPHIC image_021.jpg GRAPHIC 185630
13 GRAPHIC image_022.jpg GRAPHIC 298806
14 GRAPHIC image_023.jpg GRAPHIC 233481
15 GRAPHIC image_024.jpg GRAPHIC 333334
16 GRAPHIC image_026.jpg GRAPHIC 4329
17 GRAPHIC image_027.jpg GRAPHIC 9642
18 GRAPHIC image_029.jpg GRAPHIC 11412
19 GRAPHIC image_030.jpg GRAPHIC 10687
  Complete submission text file 0001683168-25-004258.txt   3397277

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE actu-20250531.xsd EX-101.SCH 3105
4 XBRL LABEL FILE actu-20250531_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE actu-20250531_pre.xml EX-101.PRE 22380
29 EXTRACTED XBRL INSTANCE DOCUMENT actuate_8k_htm.xml XML 3803
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42139 | Film No.: 251026754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)